Circulating Long Noncoding RNA HOTAIR is an Essential Mediator of Acute Myocardial Infarction

Insights

HOX antisense intergenic RNA (HOTAIR) is downregulated in acute myocardial infarction (AMI) patients. Upregulating HOTAIR protects heart cells from injury, suggesting HOTAIR could be a diagnostic biomarker for AMI.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Biomarker Discovery

Background:

  • Acute myocardial infarction (AMI) lacks specific diagnostic biomarkers and regulatory targets.
  • Long noncoding RNAs (lncRNAs) roles in cardiovascular disease, especially AMI, are under-explored.
  • HOX antisense intergenic RNA (HOTAIR) is a lncRNA with known roles in cancer, but its cardiac function is largely unknown.

Purpose of the Study:

  • To investigate HOTAIR expression levels in AMI.
  • To explore the functional role of HOTAIR in hypoxia-induced cardiomyocyte injury.
  • To identify potential regulatory mechanisms and diagnostic applications of HOTAIR in AMI.

Main Methods:

  • Serum HOTAIR levels were measured in AMI patients and healthy controls, correlating with cardiac troponin I (cTnI).
  • HOTAIR expression was assessed in mouse models of myocardial infarction and in hypoxic cultured cardiomyocytes.
  • Functional studies involved HOTAIR overexpression and knockdown in cardiomyocytes, alongside miRNA interaction analysis (miR-1).

Main Results:

  • HOTAIR expression was significantly decreased in AMI patients, myocardial infarction mouse models, and hypoxic cardiomyocytes.
  • Overexpression of HOTAIR reduced hypoxia-induced cardiomyocyte apoptosis, while HOTAIR knockdown exacerbated it.
  • HOTAIR exerts cardioprotective effects partly through negative regulation of miR-1.

Conclusions:

  • HOTAIR acts as a protective factor for cardiomyocytes.
  • Plasma HOTAIR concentration shows potential as a diagnostic biomarker for human AMI.
  • These findings highlight HOTAIR as a novel therapeutic target and diagnostic marker for AMI.
Abstract

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
456
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
459
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
309